|
[1]
|
Wiersinga, W.M., Poppe, K.G. and Effraimidis, G. (2023) Hyperthyroidism: Aetiology, Pathogenesis, Diagnosis, Management, Complications, and Prognosis. The Lancet Diabetes & Endocrinology, 11, 282-298. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chaker, L., Cooper, D.S., Walsh, J.P. and Peeters, R.P. (2024) Hyperthyroidism. The Lancet, 403, 768-780. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Sancak, S., Jaeschke, H., Eren, F., Ozlem, T., Guellueoglu, B., Sen, L.S., et al. (2011) High Prevalence of TSHR/Gsα Mutation-Negative Clonal Hot Thyroid Nodules (HNs) in a Turkish Cohort. Hormone and Metabolic Research, 43, 562-568. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Moroto, D., Torquato-Vieira, I.C.O., Fiorin, L.B., Camacho, C.P., Castiglioni, M.L.V., Maciel, R.M.B., et al. (2024) Long-Term Follow-Up of Patients with Autonomous Thyroid Nodules Treated with Radioiodine. Clinical Nuclear Medicine, 49, 529-535. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Vassart, G. and Dumont, J.E. (1992) The Thyrotropin Receptor and the Regulation of Thyrocyte Function and Growth. Endocrine Reviews, 13, 596-611. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Krohn, K., Führer, D., Bayer, Y., Eszlinger, M., Brauer, V., Neumann, S., et al. (2004) Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter. Endocrine Reviews, 26, 504-524. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
吕健, 栾梅香. 毒性甲状腺腺瘤21例临床分析[J]. 新疆医科大学学报, 2000(1): 26-28.
|
|
[8]
|
Goichot, B., Caron, P., Landron, F. and Bouée, S. (2015) Clinical Presentation of Hyperthyroidism in a Large Representative Sample of Outpatients in France: Relationships with Age, Aetiology and Hormonal Parameters. Clinical Endocrinology, 84, 445-451. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Demir, B.K., Karakilic, E., Saygili, E.S., Araci, N. and Ozdemir, S. (2022) Predictors of Hypothyroidism Following Empirical Dose Radioiodine in Toxic Thyroid Nodules: Real-Life Experience. Endocrine Practice, 28, 749-753. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Sjölin, G., Watt, T., Byström, K., Calissendorff, J., Cramon, P.K., Nyström, H.F., et al. (2022) Long Term Outcome after Toxic Nodular Goitre. Thyroid Research, 15, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kahraman, D., Keller, C., Schneider, C., Eschner, W., Sudbrock, F., Schmidt, M., et al. (2012) Development of Hypothyroidism during Long-Term Follow-Up of Patients with Toxic Nodular Goitre after Radioiodine Therapy. Clinical Endocrinology, 76, 297-303. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Robens, E., Spelsberg, F., Kabus, S., et al. (2001) Indications, Risks, and Acceptance of Total Thyroidectomy for Multinodular Benign Goiter. Surgery Today, 31, 958-962. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
张大闯, 李龙, 王凤军, 等. 毒性多结节性甲状腺肿的手术术式探讨[J]. 现代生物医学进展, 2014, 14(31): 6069-6072.
|
|
[14]
|
Azizi, F., Takyar, M., Madreseh, E. and Amouzegar, A. (2019) Treatment of Toxic Multinodular Goiter: Comparison of Radioiodine and Long-Term Methimazole Treatment. Thyroid, 29, 625-630. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Azizi, F., Saadat, N., Takyar, M.A., Abdi, H., Mehran, L. and Amouzegar, A. (2022) Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter. Endocrinology and Metabolism, 37, 861-869. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
李洲成, 向元楚, 钟荣国, 石斌. 原发性甲状腺功能亢进症合并甲状腺癌分析[J]. 邵阳学院学报(自然科学版), 2019, 16(1): 71-74.
|
|
[17]
|
Negro, R., Valcavi, R. and Toulis, K.A. (2013) Incidental Thyroid Cancer in Toxic and Nontoxic Goiter: Is TSH Associated with Malignany Rate? Results of a Meta-Analysis. Endocrine Practice, 19, 212-218. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Barbaro, D., Orsini, P., Lapi, P., Pasquini, C., Tuco, A., Righini, A., et al. (2007) Percutaneous Laser Ablation in the Treatment of Toxic and Pretoxic Nodular Goiter. Endocrine Practice, 13, 30-36. [Google Scholar] [CrossRef] [PubMed]
|